DRUG ENFORCEMENT ADMINISTRATION ISSUES RULE: SCHEDULES OF CONTROLLED SUBSTANCES: EXTENSION OF TEMPORARY PLACEMENT OF CLONAZOLAM, DICLAZEPAM, ETIZOLAM, FLUALPRAZOLAM, AND FLUBROMAZOLAM IN SCHEDULE I OF THE CONTROLLED SUBSTANCES ACT

WASHINGTON, July 25 -- Drug Enforcement Administration has issued a rule called: Schedules of Controlled Substances: Extension of Temporary Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act.

The rule was published in the Federal Register on July 25 by Heather Achbach, Federal Register Liaison Officer, Drug Enforcement Administration.

Summary: The Acting Administrator of the Drug Enforcement Administration (DEA) is issuing this temporary scheduling order to extend the temporary schedule I status of five designer benzodiazepines-clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam. In an order dated July 26, 2023, DEA temporarily placed these five sub...